Denali Advisors’s Arcutis Biotherapeutics ARQT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-1,200
Closed -$23K 422
2022
Q3
$23K Sell
1,200
-1,400
-54% -$26.8K 0.01% 275
2022
Q2
$55K Sell
2,600
-1,100
-30% -$23.3K 0.02% 208
2022
Q1
$71K Hold
3,700
0.03% 218
2021
Q4
$77K Buy
+3,700
New +$77K 0.03% 208